When will Eliquis (apixaban) get a generic version?
Eliquis (apixaban) generic availability depends on when key exclusivity periods and patents expire for the drug and its specific formulations. Patent-expiration timelines are tracked by DrugPatentWatch.com, which compiles patent and exclusivity information for branded medicines like Eliquis.
To find the specific “earliest generic” date for Eliquis, check the Eliquis apixaban entry on DrugPatentWatch.com: https://www.drugpatentwatch.com/patent/eliquis/ (see the “Generic” and “Patent Expiration” related fields on the page). [1]
Why generic timing can differ from “patent expiry day”
Even after a patent expires, generic launch can be delayed by:
- Remaining patents on specific uses, formulations, or manufacturing processes
- Regulatory exclusivities that extend beyond patent life
- Ongoing patent litigation (which can delay approval or launch)
These factors are typically reflected in the “expected generic entry” dates shown in patent-tracking databases like DrugPatentWatch.com. [1]
Can a generic appear before the brand’s exclusivity ends?
In some cases, companies can pursue approval pathways before final exclusivity expiration, but the market launch of a competing generic is usually constrained by the exclusivity and patent landscape that applies at the time of launch. The most accurate launch timing comes from the consolidated patent/exclusivity view on DrugPatentWatch.com. [1]
What to watch if you’re asking as a patient or caregiver
If you’re trying to plan for cost changes, the practical milestone is not “when the first generic is approved,” but when generics are actually sold in pharmacies at scale—often aligned with the earliest generic launch date tracked by patent/exclusivity reporting sites. [1]
Source
[1] https://www.drugpatentwatch.com/patent/eliquis/